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Abstract 
A commercially available probiotic, Bifidobactenum anima/is subspecies /actis (Bb12) was adapted 
to and maintained m a continuous-now chemostat culture. We evaluated the growth characteristics 
and mteractive effects of Bb12 and Salmonella typh1murium (St) when cultivated singly or together. 
When the continuous-now culture of Bb12 was challenged with 104 to 107 CFU/ml of St, the St was 
eliminated within 24 h. Th1s was replicated 3 times. Because the pH of the Bb12 was 4.5, it 
appeared that St elimination was due to the reduced pH. In a second study, St was grown in pure 
culture and the pH reduced to 4.5. Although still present, St concentrations dropped to 
unculturable levels with1n 28 h. In a th1rd study, the pH of the Bb12 culture was mamta1ned at pH 
5.6 by means of a continuous drip of NaOH and challenged with St. Although at reduced 
concentrations (1 03 CFU/ml), the St remained in the chemostat until day 9 when the drip was 
discontinued By day 14, the St was elimmated. It is apparent in these m vitro studies that Bb12 
has antagonistic properties against St and it is possible that there could be some in vivo 
applications of Bb 12 aga1nst St. 
Introduction 
Probiollcs have been defined as live microorganisms that may beneficially affect the host (following 
ingest1on) by Improving the balance of the mtest1nal m1cronora. Some of the most commonly used 
probiotics contain lactic-ac1d-producmg bactena such as Lactobacillus and Bifidobacterium species 
(Lm, 2003). Among other effects, probiotics are purported to normalize the intestinal micronora, to 
reduce gut colomzation by potential pathogens, to treat or prevent vanous types of diarrhea, to 
decrease the symptoms of irritable bowel syndrome and innammatory bowel disease, and to 
modulate 1mmune function (Un, 2003). 
Bifidobactenum are some of the earliest colomzers of the gastrointestinal (GI) tract of human 
mfanls and play an important role in the development of the permanent m1cronora. Many spec1es 
of Bifidobacterium have been louted for health benefits, but B. lactis is probably the most 
commonly used 8 lact1s conferred res1stance to s1ngle or multiple oral challenges with v1rulenl 
Salmonella lyphimurium (St) in mice (Shu et al., 2000). The authors have viewed probiotics and 
mixtures of commensal bactena as -potential mtervent1on strateg1es to 1ncrease 1mmune funct1on 
and as alternatives to anlibiot1cs to control disease associated w1th enleropalhogens such as 
Salmonella and enterotox1genic Eschench1a coli in sw1ne (Harvey et al. , 2002, Harvey el al., 2005). 
On the basis of the above-mentioned results of B lactis aga1nsl St 1n m1ce (Shu el al. , 2000), we 
hypothesized that a commercial probiolic of Bifidobacterium anima/is subspecies /actis (Bb 12) 
might have antagomslic properties agamst Salmonella colomzallon m p1gs. To test the potent1al of 
m v1vo application, we decided that we must determine the in vitro effects of Bb12 aga1nst a sw1ne 
isolate of St The purpose of the present study was to evaluate the growth characteristics and the 
interactive effects of Bb12 and St when cultivated smgly or together 1n an m vitro contmuous-now 
chemostat1c model 
Materials and methods 
B. anima/is subspecies /actis Th1s stram of baclena IS commercially available as a prob1ol1c 
(Bb12) and was obta1ned from Chr Hansen Inc. (Milwaukee, WI) A continuous-now culture of 
Bb12 was adapted to Mod1fied Reinforced Clostndia Media (MRCM), the culture established 1n a 
BioFio 110 Ferrnentor (New Brunswick Sc1enhfic, Edison. NJ) us1ng a 500 ml culture vessel w1lh an 
exchange rate of 500 mVday under anaerobic condil1ons The MRCM cons1sled of pancreatic 
digest of case1n (Cas1tone, 50 gil) proteose peptone No 3 (50 g/1), beef extract (10 0 g/1), yeast 
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extract (3 a g/1), dextrose (5 a g/1), NaCI (5.a g/1), soluble starch (1 a g/1), cysteine HCI (a.5 g/1), and 
sodium acetate (3.a g/1). 
Salmonella typhimurium (St). A primary porcine isolate of St. obtained from the National 
Vetennary Service Laboratories, Ames. lA, res1stant to 2a ~g/ml nalidiXIC ac1d (nal} and 25 ~g/ml 
novob1ocin (nov), was selected m our laboratory as the Salmonella challenge strain. For the 
continuous culture establishment of St control cultures, a 5aa ml chemostat, filled with the MRCM 
was inoculated with St and grown under anaerob1c conditions to achieve a final concentration or 
approximately 1 X 1 a5 CFU/ml The CFU of St were determined by serial dilution in phosphate 
buffered saline (PBS) and spread plat1ng on BGA that contained 2a ~g/ml nal and 25 ~g/ml nov 
and mcubated at 3JG C for 24 h. 
CFU determination of Bb12/St following challenge. 
When Bb12 and St were grown in combination , a chemostat with an established steady-state 
culture of Bb12 would be inoculated (challenged) with an overnight culture of St. CFU of St were 
determined at 3a m, 4 h, 8 h, 24 h, and 48 h after St challenge The procedures for CFU 
determmatlon were described in the previous sect1on. If BGA plates were negative for St growth, 
then 2.a ml of the chemostat med1um was added to tetrath1onate enrichment broth and mcubated 
at 3JG C for 48 h No growth after 48 h was considered a negative sample. 
The CFU for Bb12 were determmed by anaerobiC serial dilution in PBS and spread plating on 
PRAS Bifido Selective Agar (Anaerobe Systems, Morgan Hill , CA) followed by mcubat1on at 3JG C 
for 24 h 1n a Bactron IV AnaerobiC Chamber (Sheldon Manufacturing, Inc., Cornelius, OR). 
Samples for Bb12 CFU determination were collected at 3a m after St inoculation and every 24 h 
thereafter accordrng to the senal dilution procedures outlined above. 
Experimental design. 
Study A. Challenge Bb12 w1th St 
Replicate 1, challenge with 1 X 1 a4 CFU/ml 
Replicate 2, challenge with 1 X 105 CFU/ml , monrtor pH at challenge and 24 h post-
challenge 
Replicate 3, challenge wrth 1 X 1 a7 CFU/ml, monrtor pH at 4, 8, and 24 h post-
challenge 
Study B. Effects of decreased pH on St growth. 
To determ1ne the effects of reduced pH on St growth, a chemostat that had reached a steady-state 
St concentration of 1 X 1 a5 CFU/ml had concentrated HCI added every 2 h until a pH of 4 5 was 
reached Senally diluted samples were streaked onto BGA, and if necessary, were enriched with 
tetrath1onate broth. As mentioned above, a negat1ve sample was one that was negative on BGA 
and had no growth after 48 h incubation in tetrathionate broth. 
Study C. Effects of 1ncreased pH on St challenge of Bb12. 
We hypothesized that 1ncreased pH in the chemostat could favor the colonization of St when grown 
m combination with Bb12 Following St challenge of an established culture of Bb12, we mamtamed 
a pH of 5.6 to 5 8 by the addit1on of sterile anaerob1c NaOH (a 48 M) by cont1nuous dnp at a rate of 
approx1mately 82 a ml/24 h (a.5%). 
Results and Discussion 
In study A, there was no growth of St on Brilliant Green Agar (BGA, Oxo1d Ltd , Basmgstoke, UK) 
at 24 h, 48 h, and 24 h post-challenge in replicates 1, 2, and 3, respectively, and were negative 
following enrichment The pH or the Bb12 culture at challenge ranged from 4 42 to 4.5a, before, 
dunng, and 24 h post-challenge 1n replicates 2 and 3 
Within 24 h in study B, St decreased from 1a6 CFU/ml at pH 5.6 to 1a3 CFU/ml at pH 4.5 By 28 h, 
the BGA plates were negative for St growth and contmued to be negat1ve though day 13 We 
contmued to add hydrochloric ac1d (HCI) throughout 168 h (d 7), but at 192 h (d 8) we 
discontinued The pH then slowly returned to 5 6 by day 13 Although BGA plates continued to be 
negative dunng this study, the tetrath1onate-broth-ennched samples were cons1stently pos1t1ve 
throughout day 13 when we term1nated the study 
In study C, by 24 h post-challenge, St concentrations were 1a4 CFU/ml whereas Bb12 was at 108 
CFU/ml By day 9 when we turned off the contmuous dnp of sod1um hydroxide (NaOH), the counts 
were 1 a3 CFU/ml forSt and 1 a5 CFU/ml for Bb12 The pH went from 57 on day 9 to 4 7 on day 1a 
while the counts were 1a1 CFU/ml for St and 1a4 CFU/ml for Bb12 Beginning on day 11 and 
continuing through day 13, the sample for St was negative on BGA plates, but positive in 
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tetrathionate broth. On day 14, the tetrathionate-enriched samples were negative forSt, the pH 
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Figure. Study C lnteract1on of Bb12 ( A ) and St (• ) when grown simultaneously in continuous 
-now culture w1th pH (• ) at 5.6 to 5.8 pH was adjusted by continuous dnp of NaOH. At 216 h 
(see arrow), the drip was discontinued. 
In study A, Bb12 produced dramatic reduct1ons of St 1n the chemostat. Because Bb12 produces 
lactic ac1d and the culture consistently mainta1ned the pH at 4 42 to 4.50, we assumed that the 
elimmatlon of St was due to the lowered pH. To test th1s hypothesis, we then conducted study B 
with St alone 1n a reduced pH enwonment Wh1le the decrease 1n pH slowed the growth and 
reduced the CFU to a non-culturable level, pH alone did not stenlize the chemostat. Although pH 
appeared to have a great mOuence on St colon1zat1on, the results from th1s study showed that 1t 1s 
not the only factor 1n elimmatlon. Hence, we des1gned study C 1n wh1ch 1ncreased pH should favor 
the growth of Stand offset the acid-producing properties of Bb12 Study C suggested that Bb12 
had some bactenostat1c properties agamst St because at 24 h post-challenge, St was 104 CFU/ml 
and by day 9 the CFU was 103 During that same time frame, Bb12 concentrations were also 
decreasmg Followmg the removal of the NaOH dnp, Bb12 concentrations went up to 107 CFU/ml 
and St was elimmated from the chemostat 
While not conclusive, these results suggest that Bb12 may have some antagonistic properties 
against St. Our results are s1m1lar to another m vttro study (81elecka et al. , 1998) 1n which 8 . 
ammalis was bactericidal to S enteritidis. B lactis has been shown to enhance res1stance to oral 
challenge of m1ce with S typhtmurium, mclud1ng a ten-fold surv1val rate 1n treated m1ce (Shu et al. , 
2000) 
Wh1le the authors are not suggesting that m vtlro data can be directly applied to in vivo 
conclusions, there are m vtvo studies that show B lactis (Bb12) added to mfant formula had 
ameliorating effects on Gl tract disease (We1zman, 2005), that consumption of B. bifidum {Bb12) 
increases leukocyte phagocytosis 1n human subjects (Schiffrin et al , 1995), that mgestlon of B. 
lactts can enhance natural immunity in elderly human subjects (Arunachalam et al , 2000), and that 
prob1ot1cs such as Btfidobactenum have a major impact on the development and maintenance of 
1mmune function (lsolauri et al . 2001 ) 
We do not know the mechamsm of action for the antagonism of Bb 12 on St but 1t 1s known that 
early colonization of the Gl tract by commensal bacteria can competitively exclude 
enteropathogens such as Salmonella and Eschenchta coli It has been sa1d that commensals 
reduce pathogen colonization by competition for nutrients. compet1t1on for receptor s1tes, 
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stimulation of the immune system, and production of bacteriocidal products such as bacteriocins 
(HaNey et al. , 2005). 
We conclude that Bb12 can eliminate St in a continuous-flow chemostat culture and although it 
appears primarily due to reduced pH that 1nh1b1ts St replication , our results suggest that other 
factors may play a role in St reduction . It IS possible that there may be in v1vo applications of Bb12 
against St. 
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